Global Nuclear Medicine Market Size, Growth, Trends, Industry Analysis and Forecast 2020

Market Reports Center
One Stop Market Reaserch Shop
Global Nuclear Medicine Market Size, Share, Global Insights, Analysis
and Outlook, Emerging Trends and Research Report by Market Reports
Center
Technavio Announces the Publication of its Research Report – Global Nuclear Medicine Market 2016-2020
Technavio recognizes the following companies as the key players in the global nuclear medicine market:
Cardinal Health, Digirad, GE Healthcare, Lantheus Medical Imaging, and Philips Healthcare.
Other Prominent Vendors in the market are:
ABT Molecular Imaging, Advanced Accelerator Applications, AGFA Healthcare, Algeta, Astellas Pharma,
Bayer, Bracco Imaging, Brain Biosciences, Capintec, CMR Naviscan, Cubresa, Eczacibasi-Monrol Nuclear
Products, FUJIFILM Holdings, IBA Molecular Imaging, ISOLOGIC Innovative Radiopharmaceuticals, Jubilant
DraxImage, Mallinckrodt, Mediso Medical Imaging System, Mirada Medical, Navidea Biopharmaceuticals,
Nordion, Piramal Imaging, Positron Pharmaceutical Company, RadioMedix, SHINE Medical Technologies,
Sophie Biosciences, Toshiba Medical Systems, Triad Isotopes, and Voxel.
Browse full report with TOC@ https://marketreportscenter.com/reports/328681/global-nuclearmedicine-market-2016-2020
Commenting on the report, an analyst from Technavio’ s team said: “Partnerships for development of
nuclear medicine is a key trend. Many nuclear medicine and nuclear imaging companies are forming
partnerships to solve longstanding radiopharmaceutical concerns in medical imaging and increase the
market share of vendors. These partnerships will increase the production of low cost
radiopharmaceuticals,
which
will
boost
the
growth
of
the
market.”
According to the report, the demand for radiopharmaceuticals is high in the global nuclear medicine
market. Most radioactive compounds are used for diagnostic procedures and a few are used for
Market Reports Center
One Stop Market Reaserch Shop
therapeutic purposes. Regulatory bodies such as the FDA are approving radiopharmaceuticals for
expanded use.
Further, the report states that radiopharmaceuticals are highly expensive and can be a financial burden
for the healthcare industry if nuclear medicines stay unutilized. Studies show that around 16%
radiopharmaceuticals
in
the
US
remained
unutilized
in
2014.
The study was conducted using an objective combination of primary and secondary information including
inputs from key participants in the industry. The report contains a comprehensive market and vendor
landscape in addition to a SWOT analysis of the key vendors.
Request A Sample copy of This Report @ https://marketreportscenter.com/request-sample/328681
Covered in this report
About Nuclear Medicine
Nuclear medicine is a specialty branch of medical imaging that involves the use of modalities such as
SPECT and PET scans. These technologies help detect and evaluate various disorders in the areas of
oncology, cardiology, and neurology. Modalities for nuclear medicine involve the use of a minimal
amount of radioisotopes that are either injected, swallowed, or inhaled by an individual. These
radioisotopes reach the specific organ targeted by the pharmaceutical compound and emit radiations
that can be detected using a scanner or a detector.
Technavio’ s analysts forecast the global nuclear medicine market to grow at a CAGR of 8.34% during the
period 2016-2020.
Covered in this report
The report covers the present scenario and the growth prospects of the global nuclear medicine market
for 2016-2020. To calculate the market size, the report considers the use revenue generated from the
sales of various types of imaging equipment and radiopharmaceuticals that are used for diagnosis and
therapeutic purposes.
The market is divided into the following segments based on geography:
Americas
EMEA
APAC
Technavio's report, Global Nuclear Medicine Market 2016-2020, has been prepared based on an indepth market analysis with inputs from industry experts. The report covers the market landscape and its
growth prospects over the coming years. The report also includes a discussion of the key vendors
operating in this market.
Key vendors
Cardinal Health
Market Reports Center
One Stop Market Reaserch Shop
Digirad
GE Healthcare
Lantheus Medical Imaging
Philips Healthcare
Other prominent vendors
ABT Molecular Imaging
Advanced Accelerator Applications
AGFA Healthcare
Algeta
Astellas Pharma
Bayer
Bracco Imaging
Brain Biosciences
Capintec
CMR Naviscan
Cubresa
Eczacibasi-Monrol Nuclear Products
FUJIFILM Holdings
IBA Molecular Imaging
ISOLOGIC Innovative Radiopharmaceuticals
Jubilant DraxImage
Mallinckrodt
Mediso Medical Imaging System
Mirada Medical
Navidea Biopharmaceuticals
Nordion
Piramal Imaging
Positron Pharmaceutical Company
RadioMedix
SHINE Medical Technologies
Sophie Biosciences
Toshiba Medical Systems
Triad Isotopes
Voxel
Market driver
Growing demand for radiopharmaceuticals
For a full, detailed list, view our report
Market challenge
High cost of nuclear medicine and time constraints owing to its short half-life
For a full, detailed list, view our report
Market trend
Partnerships for development of nuclear medicine
For a full, detailed list, view our report
Market Reports Center
One Stop Market Reaserch Shop
Key questions answered in this report
What will the market size be in 2020 and what will the growth rate be?
What are the key market trends?
What is driving this market?
What are the challenges to market growth?
Who are the key vendors in this market space?
What are the market opportunities and threats faced by the key vendors?
What are the strengths and weaknesses of the key vendors?
You can request one free hour of our analyst’ s time when you purchase this market report. Details are
provided within the report.
To Get Discount On The Report @ https://marketreportscenter.com/request-discount/328681
Connect for more details:
Sam Collins
Market Reports Center
1-646-883-3044 (US)
info@marketreportscenter.com

According to the report, the demand for radiopharmaceuticals is high in the global nuclear medicine market. Most radioactive compounds are used for diagnostic procedures and a few are used for therapeutic purposes.